To analyze the decline in primary care specialty choice among internal medicine residents and identify specific structural factors, such as funding disparities and training environments, contributing to this trend.
Key Findings:
Fewer than 9% of internal medicine residents chose primary care in 2024–2025, a significant decline from a decade ago, highlighting a critical workforce issue.
The average medical student graduates with over $200,000 in debt, a financial burden that heavily influences specialty choice.
Despite providing 35% of ambulatory services, primary care receives less than 5% of total health care spending, indicating a misallocation of resources.
Internal medicine residents spend over 70% of their training on inpatient services due to funding structures that favor teaching hospitals, limiting exposure to primary care.
A 'hidden curriculum' exists that devalues primary care, steering residents towards subspecialty training.
Interpretation:
The decline in primary care is attributed to systemic issues in medical education and funding, rather than individual preferences, leading to a significant workforce shortage that threatens patient care.
Limitations:
Reforming graduate medical education funding requires federal action, which is politically challenging and slow, compounded by resistance from subspecialists who benefit from the current reimbursement structure.
Conclusion:
The current structure of medical education and funding undermines the supply of primary care physicians, necessitating immediate and decisive action from medical institutions to rectify this imbalance.
A meta-analysis of placebo-controlled crossover trials found reduced aerobic time-trial completion times with both low- and moderate-dose oral anhydrous caffeine, but the evidence was mostly derived from male participants, cycling studies, and trials using doses no higher than 6 mg/kg.
A randomized clinical trial found higher chronic GVHD-free survival and lower rates of serious chronic GVHD compared with standard transplantation in adults with blood cancers.